PLGF2 Human, HEK

Placental Growth Factor-2, HEK Human Recombinant

PLGF2 Human Recombinant produced in HEK293 cells is a single, glycosylated polypeptide chain (a.a 19-170) containing 158 amino acids and having a molecular mass of 18.1kDa. PLGF2 is fused to a 6 amino acid His tag at C-terminus and purified by proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT28805
Source

HEK293 cells.

Appearance

Sterile Filtered colorless solution.

PLGF3 Human

Placental Growth Factor-3 Human Recombinant

PLGF3 Human Recombinant produced in E.Coli is a non-glycosylated homodimer containing 2x204 amino acids and having a total molecular mass of 45.8kDa.
Shipped with Ice Packs
Cat. No.
BT28885
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

PLGF3 Human, sf9

Placental Growth Factor-3 Human Recombinant, sf9

PLGF3 Human Recombinant produced in Spodoptera frugiperda is a glycosylated homodimer containing 2 chains of 203 amino acids (Leu19-Arg221) and having a molecular mass of 58kDa.
The PLGF-3 is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT28987
Source
Spodoptera frugiperda.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Definition and Classification

Placental Growth Factor (PlGF) is a protein encoded by the PGF gene in humans. It belongs to the vascular endothelial growth factor (VEGF) family, which is crucial for angiogenesis and vasculogenesis, particularly during embryogenesis . PlGF is primarily expressed in the placenta but is also found in other tissues .

Biological Properties

Key Biological Properties: PlGF is a heparin-binding protein that can form homodimers and heterodimers. It binds to receptors such as FLT1/VEGFR-1 and, in some isoforms, to NRP1/neuropilin-1 and NRP2/neuropilin-2 .

Expression Patterns: PlGF is predominantly expressed in the placental trophoblast during pregnancy. It is also expressed in various tissues, including the renal medulla, cardia, pylorus, and others .

Tissue Distribution: PlGF is found in the placenta, heart, lung, thyroid, liver, skeletal muscle, and bone . Its expression is particularly high in the placenta, where it plays a significant role in fetal development .

Biological Functions

Primary Biological Functions: PlGF is involved in angiogenesis, the formation of new blood vessels from pre-existing ones. It promotes the proliferation and migration of endothelial cells . PlGF also plays a role in the recruitment and maturation of bone marrow-derived progenitors involved in the angiogenic process .

Role in Immune Responses and Pathogen Recognition: PlGF has been shown to promote the differentiation and activation of monocyte-macrophage lineage cells, which support the angiogenic stimulus .

Modes of Action

Mechanisms with Other Molecules and Cells: PlGF interacts with receptors such as FLT1/VEGFR-1 and NRP1/neuropilin-1. These interactions trigger downstream signaling cascades that promote angiogenesis and endothelial cell growth .

Binding Partners: PlGF binds to FLT1/VEGFR-1 and, in some isoforms, to NRP1/neuropilin-1 and NRP2/neuropilin-2 in a heparin-dependent manner .

Downstream Signaling Cascades: The binding of PlGF to its receptors activates signaling pathways that lead to the proliferation and migration of endothelial cells, contributing to angiogenesis .

Regulatory Mechanisms

Transcriptional Regulation: The expression of PlGF is regulated at the transcriptional level. Factors such as hypoxia can induce the expression of PlGF .

Post-Translational Modifications: PlGF is secreted as a glycosylated homodimer. Isoforms PlGF-1 and PlGF-3 are diffusible, while PlGF-2 and PlGF-4 have heparin-binding domains and remain cell membrane-associated .

Applications

Biomedical Research: PlGF is used in research to understand its role in angiogenesis and its potential therapeutic applications .

Diagnostic Tools: PlGF levels in maternal blood are used to predict and diagnose pre-eclampsia, a pregnancy complication characterized by high blood pressure and damage to other organs .

Therapeutic Strategies: PlGF is being explored as a therapeutic target for conditions such as fetal growth restriction and preeclampsia. Gene therapy approaches are being investigated to enhance PlGF expression and improve placental function .

Role in the Life Cycle

Development: PlGF plays a crucial role in embryonic development by promoting angiogenesis and vasculogenesis .

Aging and Disease: Dysregulation of PlGF expression is associated with various diseases, including pre-eclampsia and other pregnancy-related complications . PlGF is also being studied for its potential role in cardiovascular diseases and cancer .

© Copyright 2024 Thebiotek. All Rights Reserved.